Humana Inc. (HUM) EV/Sales Ratio: 0.39x
Is Humana Inc.’s EV/Sales ratio high or low?
Humana Inc.'s EV/Sales ratio of 0.39x is 28% below its 5-year average of 0.54x, near the low end of its 5-year range (0.22x–0.87x).
The EV/Sales ratio for Humana Inc. (HUM) is 0.39x as of Tuesday, June 9, 2026. It is above its 12-month average by 29.38% (0.30x).
HUM EV/Sales Ratio Chart
HUM Average EV/Sales Ratio Chart
HUM Current vs Average EV/Sales Ratio Chart
HUM EV/Sales Ratio Metrics
EV/SALES RATIO
0.39x
EV/SALES RATIO AVG TTM
0.30x
EV/SALES RATIO AVG 3Y
0.40x
EV/SALES RATIO AVG 5Y
0.54x
EV/SALES RATIO AVG 10Y
0.61x
EV/SALES RATIO AVG 15Y
0.55x
EV/SALES RATIO AVG 20Y
0.49x
CURRENT VS TTM AVG
+29.38%
CURRENT VS 3Y AVG
-2.75%
CURRENT VS 5Y AVG
-27.62%
CURRENT VS 10Y AVG
-35.81%
CURRENT VS 15Y AVG
-28.84%
CURRENT VS 20Y AVG
-21.04%
HUM Competitors' EV/Sales Ratio
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humana Inc. (HUM) | — | 0.39x | 0.30x | 0.40x | 0.54x |
| IDEXX Laboratories, Inc. (IDXX) | $45.66B | 10.70x | 12.34x | 11.51x | 12.39x |
| Agilent Technologies, Inc. (A) | $38.26B | 5.53x | 5.56x | 5.75x | 6.21x |
| Zoetis Inc. (ZTS) | $34.46B | 4.42x | 6.74x | 8.79x | 9.91x |
| Centene Corporation (CNC) | $32.69B | 0.14x | 0.11x | 0.20x | 0.29x |
| IQVIA Holdings Inc. (IQV) | $31.09B | 1.91x | 2.84x | 3.22x | 3.53x |
| DexCom, Inc. (DXCM) | $30.17B | 6.44x | 6.65x | 10.24x | 13.90x |
| Biogen Inc. (BIIB) | $29.39B | 3.32x | 2.78x | 3.30x | 3.58x |
| Veeva Systems Inc. (VEEV) | $27.37B | 7.85x | 12.54x | 13.33x | 15.72x |
| Waters Corporation (WAT) | $24.19B | 9.44x | 7.02x | 7.12x | 7.32x |
Understanding EV/Sales
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
- It works for unprofitable companies where P/E doesn't apply
- Revenue is harder to manipulate than earnings
- It supports comparisons across companies at different profitability stages
- It is frequently used for software and other revenue-growth-focused companies
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
Humana Inc. EV/Sales Ratio Formula & Definition
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Humana Inc. EV/Sales Ratio FAQ
- What is the EV/Sales ratio for Humana Inc. (HUM)?
- The EV/Sales ratio for HUM stock is 0.39x.
- Is Humana Inc.'s EV/Sales ratio high or low?
- Humana Inc.'s EV/Sales ratio of 0.39x is 28% below its 5-year average of 0.54x, near the low end of its 5-year range (0.22x–0.87x).
- What is the TTM average EV/Sales ratio for Humana Inc. (HUM)?
- The TTM average EV/Sales ratio for HUM stock is 0.30x.
- What is the 3Y average EV/Sales ratio for Humana Inc. (HUM)?
- The 3Y average EV/Sales ratio for HUM stock is 0.40x.
- What is the 5Y average EV/Sales ratio for Humana Inc. (HUM)?
- The 5Y average EV/Sales ratio for HUM stock is 0.54x.
- What is the 10Y average EV/Sales ratio for Humana Inc. (HUM)?
- The 10Y average EV/Sales ratio for HUM stock is 0.61x.
- What is the 15Y average EV/Sales ratio for Humana Inc. (HUM)?
- The 15Y average EV/Sales ratio for HUM stock is 0.55x.
- What is the 20Y average EV/Sales ratio for Humana Inc. (HUM)?
- The 20Y average EV/Sales ratio for HUM stock is 0.49x.
Humana Inc. EV/Sales Ratio History
| DATE | EV/SALES RATIO |
|---|---|
| 2026-06-09 | 0.39x |
| 2026-06-08 | 0.38x |
| 2026-06-05 | 0.37x |
| 2026-06-04 | 0.37x |
| 2026-06-03 | 0.35x |
| 2026-06-02 | 0.35x |
| 2026-06-01 | 0.35x |
| 2026-05-29 | 0.33x |
| 2026-05-28 | 0.34x |
| 2026-05-27 | 0.34x |
| 2026-05-26 | 0.33x |
| 2026-05-22 | 0.34x |
| 2026-05-21 | 0.33x |
| 2026-05-20 | 0.33x |
| 2026-05-19 | 0.34x |
| 2026-05-18 | 0.33x |
| 2026-05-15 | 0.33x |
| 2026-05-14 | 0.33x |
| 2026-05-13 | 0.33x |
| 2026-05-12 | 0.33x |
| 2026-05-11 | 0.31x |
| 2026-05-08 | 0.31x |
| 2026-05-07 | 0.28x |
| 2026-05-06 | 0.28x |
| 2026-05-05 | 0.28x |
| 2026-05-04 | 0.28x |
| 2026-05-01 | 0.27x |
| 2026-04-30 | 0.27x |
| 2026-04-29 | 0.28x |
| 2026-04-28 | 0.28x |
| 2026-04-27 | 0.28x |
| 2026-04-24 | 0.27x |
| 2026-04-23 | 0.27x |
| 2026-04-22 | 0.27x |
| 2026-04-21 | 0.27x |
| 2026-04-20 | 0.26x |
| 2026-04-17 | 0.26x |
| 2026-04-16 | 0.25x |
| 2026-04-15 | 0.25x |
| 2026-04-14 | 0.25x |
| 2026-04-13 | 0.25x |
| 2026-04-10 | 0.25x |
| 2026-04-09 | 0.25x |
| 2026-04-08 | 0.25x |
| 2026-04-07 | 0.25x |
| 2026-04-06 | 0.24x |
| 2026-04-02 | 0.23x |
| 2026-04-01 | 0.23x |
| 2026-03-31 | 0.23x |
| 2026-03-30 | 0.22x |
| 2026-03-27 | 0.22x |
| 2026-03-26 | 0.23x |
| 2026-03-25 | 0.23x |
| 2026-03-24 | 0.23x |
| 2026-03-23 | 0.23x |
| 2026-03-20 | 0.23x |
| 2026-03-19 | 0.22x |
| 2026-03-18 | 0.23x |
| 2026-03-17 | 0.23x |
| 2026-03-16 | 0.23x |
| 2026-03-13 | 0.22x |
| 2026-03-12 | 0.22x |
| 2026-03-11 | 0.23x |
| 2026-03-10 | 0.23x |
| 2026-03-09 | 0.23x |
| 2026-03-06 | 0.23x |
| 2026-03-05 | 0.24x |
| 2026-03-04 | 0.24x |
| 2026-03-03 | 0.24x |
| 2026-03-02 | 0.24x |
| 2026-02-27 | 0.24x |
| 2026-02-26 | 0.24x |
| 2026-02-25 | 0.23x |
| 2026-02-24 | 0.23x |
| 2026-02-23 | 0.24x |
| 2026-02-20 | 0.24x |
| 2026-02-19 | 0.24x |
| 2026-02-18 | 0.24x |
| 2026-02-17 | 0.23x |
| 2026-02-13 | 0.23x |
| 2026-02-12 | 0.23x |
| 2026-02-11 | 0.22x |
| 2026-02-10 | 0.23x |
| 2026-02-09 | 0.24x |
| 2026-02-06 | 0.24x |
| 2026-02-05 | 0.24x |
| 2026-02-04 | 0.24x |
| 2026-02-03 | 0.24x |
| 2026-02-02 | 0.24x |
| 2026-01-30 | 0.24x |
| 2026-01-29 | 0.25x |
| 2026-01-28 | 0.24x |
| 2026-01-27 | 0.26x |
| 2026-01-26 | 0.31x |
| 2026-01-23 | 0.31x |
| 2026-01-22 | 0.31x |
| 2026-01-21 | 0.32x |
| 2026-01-20 | 0.31x |
| 2026-01-16 | 0.32x |
| 2026-01-15 | 0.33x |
| 2026-01-14 | 0.32x |
| 2026-01-13 | 0.32x |
| 2026-01-12 | 0.32x |
| 2026-01-09 | 0.32x |
| 2026-01-08 | 0.32x |
| 2026-01-07 | 0.32x |
| 2026-01-06 | 0.32x |
| 2026-01-05 | 0.32x |
| 2026-01-02 | 0.31x |
| 2025-12-31 | 0.30x |
| 2025-12-30 | 0.30x |
| 2025-12-29 | 0.30x |
| 2025-12-26 | 0.30x |
| 2025-12-24 | 0.30x |
| 2025-12-23 | 0.30x |
| 2025-12-22 | 0.30x |
| 2025-12-19 | 0.31x |
| 2025-12-18 | 0.31x |
| 2025-12-17 | 0.31x |
| 2025-12-16 | 0.30x |
| 2025-12-15 | 0.32x |
| 2025-12-12 | 0.31x |
| 2025-12-11 | 0.31x |
| 2025-12-10 | 0.30x |
| 2025-12-09 | 0.30x |
| 2025-12-08 | 0.30x |
| 2025-12-05 | 0.30x |
| 2025-12-04 | 0.30x |
| 2025-12-03 | 0.30x |
| 2025-12-02 | 0.29x |
| 2025-12-01 | 0.29x |
| 2025-11-28 | 0.29x |
| 2025-11-26 | 0.29x |
| 2025-11-25 | 0.28x |
| 2025-11-24 | 0.28x |
| 2025-11-21 | 0.27x |
| 2025-11-20 | 0.27x |
| 2025-11-19 | 0.28x |
| 2025-11-18 | 0.28x |
| 2025-11-17 | 0.28x |
| 2025-11-14 | 0.28x |
| 2025-11-13 | 0.28x |
| 2025-11-12 | 0.29x |
| 2025-11-11 | 0.29x |
| 2025-11-10 | 0.29x |
| 2025-11-07 | 0.30x |
| 2025-11-06 | 0.30x |
| 2025-11-05 | 0.31x |
| 2025-11-04 | 0.35x |
| 2025-11-03 | 0.34x |
| 2025-10-31 | 0.34x |
| 2025-10-30 | 0.35x |
| 2025-10-29 | 0.36x |
| 2025-10-28 | 0.36x |
| 2025-10-27 | 0.36x |
| 2025-10-24 | 0.35x |
| 2025-10-23 | 0.36x |
| 2025-10-22 | 0.35x |
| 2025-10-21 | 0.36x |
| 2025-10-20 | 0.35x |
| 2025-10-17 | 0.34x |
| 2025-10-16 | 0.33x |
| 2025-10-15 | 0.33x |
| 2025-10-14 | 0.33x |
| 2025-10-13 | 0.34x |
| 2025-10-10 | 0.34x |
| 2025-10-09 | 0.35x |
| 2025-10-08 | 0.36x |
| 2025-10-07 | 0.36x |
| 2025-10-06 | 0.36x |
| 2025-10-03 | 0.35x |
| 2025-10-02 | 0.32x |
| 2025-10-01 | 0.31x |
| 2025-09-30 | 0.32x |
| 2025-09-29 | 0.32x |
| 2025-09-26 | 0.32x |
| 2025-09-25 | 0.32x |
| 2025-09-24 | 0.33x |
| 2025-09-23 | 0.32x |
| 2025-09-22 | 0.32x |
| 2025-09-19 | 0.32x |
| 2025-09-18 | 0.33x |
| 2025-09-17 | 0.33x |
| 2025-09-16 | 0.34x |
| 2025-09-15 | 0.34x |
| 2025-09-12 | 0.34x |
| 2025-09-11 | 0.34x |
| 2025-09-10 | 0.34x |
| 2025-09-09 | 0.34x |
| 2025-09-08 | 0.37x |
| 2025-09-05 | 0.37x |
| 2025-09-04 | 0.38x |
| 2025-09-03 | 0.38x |
| 2025-09-02 | 0.37x |
| 2025-08-29 | 0.37x |
| 2025-08-28 | 0.36x |
| 2025-08-27 | 0.36x |
| 2025-08-26 | 0.36x |
| 2025-08-25 | 0.36x |
| 2025-08-22 | 0.36x |
| 2025-08-21 | 0.36x |
| 2025-08-20 | 0.35x |
| 2025-08-19 | 0.35x |
| 2025-08-18 | 0.35x |
| 2025-08-15 | 0.35x |
| 2025-08-14 | 0.35x |
| 2025-08-13 | 0.35x |
| 2025-08-12 | 0.34x |
| 2025-08-11 | 0.33x |
| 2025-08-08 | 0.33x |
| 2025-08-07 | 0.32x |
| 2025-08-06 | 0.32x |
| 2025-08-05 | 0.32x |
| 2025-08-04 | 0.31x |
| 2025-08-01 | 0.31x |
| 2025-07-31 | 0.31x |
| 2025-07-30 | 0.33x |
| 2025-07-29 | 0.31x |
| 2025-07-28 | 0.31x |
| 2025-07-25 | 0.31x |
| 2025-07-24 | 0.31x |
| 2025-07-23 | 0.31x |
| 2025-07-22 | 0.31x |
| 2025-07-21 | 0.30x |
| 2025-07-18 | 0.30x |
| 2025-07-17 | 0.30x |
| 2025-07-16 | 0.30x |
| 2025-07-15 | 0.30x |
| 2025-07-14 | 0.30x |
| 2025-07-11 | 0.31x |
| 2025-07-10 | 0.31x |
| 2025-07-09 | 0.31x |
| 2025-07-08 | 0.31x |
| 2025-07-07 | 0.31x |
| 2025-07-03 | 0.32x |
| 2025-07-02 | 0.32x |
| 2025-07-01 | 0.33x |
| 2025-06-30 | 0.32x |
| 2025-06-27 | 0.32x |
| 2025-06-26 | 0.32x |
| 2025-06-25 | 0.31x |
| 2025-06-24 | 0.32x |
| 2025-06-23 | 0.31x |
| 2025-06-20 | 0.32x |
| 2025-06-18 | 0.32x |
| 2025-06-17 | 0.32x |
| 2025-06-16 | 0.31x |
| 2025-06-13 | 0.31x |
| 2025-06-12 | 0.31x |
| 2025-06-11 | 0.31x |
| 2025-06-10 | 0.31x |
| 2025-06-09 | 0.31x |
| 2025-06-06 | 0.31x |
| 2025-06-05 | 0.30x |
| 2025-06-04 | 0.31x |
| 2025-06-03 | 0.31x |
| 2025-06-02 | 0.31x |
| 2025-05-30 | 0.31x |
| 2025-05-29 | 0.31x |
| 2025-05-28 | 0.30x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin